CDH1 hypermethylation: a potential molecular pathway for invasiveness in glioblastoma.

Belut, Daniel R; Lima, Estela de O; Zanini, Marco A; Galvani, Aline F; Furtado, Fabiana B; Ferrasi, Adriana C

Belut, Daniel R; Lima, Estela de O; Zanini, Marco A; Galvani, Aline F; Furtado, Fabiana B; Ferrasi, Adriana C.

Afiliação

Belut DR; Department of Internal Medicine, Botucatu Medical School, UNESP - Sao Paulo State University.
Lima EO; Department of Internal Medicine, Botucatu Medical School, UNESP - Sao Paulo State University.
Zanini MA; Department of Neurology, Psychology and Psychiatry, Botucatu Medical School, UNESP - Sao Paulo State University.
Galvani AF; Department of Internal Medicine, Botucatu Medical School, UNESP - Sao Paulo State University.
Furtado FB; Laboratory of Applied Biotechnology, Brazil Clinical Hospital of Botucatu Medical School (HCFMB), Sao Paulo State University (UNESP), Botucatu, Brazil.
Ferrasi AC; Department of Internal Medicine, Botucatu Medical School, UNESP - Sao Paulo State University.

Eur J Cancer Prev ; 33(1): 73-btii, 2024 Jan 01.

Article em En | MEDLINE | ID: mdl-37401481

Assuntos

Glioblastoma; Humanos; Glioblastoma/genética; Regiões Promotoras Genéticas; Metilação de DNA; Caderinas/genética; Reação em Cadeia da Polimerase; Prognóstico; Antígenos CD/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Eur J Cancer Prev Assunto da revista: NEOPLASIAS / SAUDE PUBLICA Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google